Unlocking Cross-Border Healthcare Innovation
Our captive-asset platform delivers exclusive, high-quality deal flow across a $100M fund bridging Latin American healthcare innovation with USA/EU life sciences markets.
Explore Our Portfolio
Bridging Markets, Transforming Healthcare
We create powerful connections between Latin American healthcare innovations and US/EU markets, driving mutual growth and expanding access to quality care.
Unlocking Emerging Market Innovation
We identify and nurture groundbreaking healthcare solutions developed in Latin America that solve critical regional challenges with global potential.
Strategic Market Bridge
Our platform validates life sciences & healthcare assets, providing seamless pathways for cross-border expansion, connecting innovative solutions with capital, expertise, and distribution networks.
US/EU Market Expansion
We provide US/EU healthcare companies strategic entry points to the growing Latin American market while bringing LatAm innovations to developed markets.
By connecting these vibrant ecosystems, we're serving 700+ million underserved patients while creating unprecedented expansion opportunities for companies on both sides of the border.
Our Investment Strategy
Our cross-border investment approach combines strategic capital allocation with deep healthcare expertise. We target high-potential healthcare innovations in Latin America and facilitate their expansion into US/EU markets, while supporting developed market companies entering LatAm — creating a robust ecosystem that maximizes returns and healthcare impact.
Geographic Allocation
50% capital deployment in Latin America, 50% in USA/EU markets
Investment Stage
70% focused on Seed and Series A rounds, 30% allocated to Pre-seed opportunities
Sector Focus
Digital health, biotech, medical devices, and next-generation diagnostics
Partnership Model
Backed by institutional LPs with strategic regional co-investors
Our Advantage
Transforming Healthcare Through Captive Asset Sandbox Platforms
Clinical Trial Validation Platform
Vantage, Our proprietary clinical-validation platform in Kazakhstan revolutionizes R&D by dramatically shortening time to proof-of-concept, while providing a robust real-world test environment for cutting-edge healthcare software and service innovations.
  • Accelerated development cycles with 2-3x faster time-to-market at 30% cost
  • Unparalleled access to data-rich patient populations
Health Innovation Sandbox
Catalyst, Our state-of-the-art innovation lab, strengthened by strategic hospital system partnerships, enables iterative testing and rapid refinement of healthcare solutions in authentic clinical environments while ensuring strict compliance with local standards.
This comprehensive approach allows us to see around corners, de-risking opportunities before scaling across millions of potential patients in diverse healthcare systems.
Market Opportunity
Unlocking unprecedented growth at the intersection of innovation and untapped healthcare needs
700M
Population Reach
Latin American market with rapidly increasing healthcare expenditure
3-5x
Valuation Arbitrage
Multiple between Latin American and USA/EU healthcare companies
18%+
Digital Health CAGR
Accelerated growth across Latin America since 2020
3+
Exit Pathways
US M&A, regional IPOs, and strategic acquisitions
Join Us: Shape the Next Era of Health Innovation
Co-Invest
Partner on high-potential deals across our pipeline
Connect
Refer opportunities or join our expert network
Engage
Access proprietary healthcare innovation insights
Ready to transform healthcare across continents? Contact our team to explore partnership opportunities or subscribe to our newsletter for exclusive market insights and investment updates.